APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pregnancy Medication

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Pregnancy Medication Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

30 December 2025192 pages

Choose your research edition.

Industry ResearchPregnancy Medication Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Pregnancy Medication Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Pregnancy Medication Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pregnancy Medication Market Outlook and Growth Opportunities 2026200 pages · $4,250 USDMarket Analysis & ForecastGlobal Pregnancy Medication Market Analysis and Forecast 2026-2032202 pages · $4,950 USD

Market perspective

The global Pregnancy Medication market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Pregnancy Medication is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pregnancy Medication is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pregnancy Medication is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Pregnancy Medication is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Pregnancy Medication include Janssen, Takeda, Sanofi, Pfizer, GSK, AbbVie, Viatris Inc(Mylan Inc.), Sun Pharma and Roche Holding AG, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Pregnancy Medication market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pregnancy Medication and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pregnancy Medication sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pregnancy Medication market size, projected growth trends, production technologies, key applications, and end-use industries.

Pregnancy Medication Segment by Company

Janssen

Takeda

Sanofi

Pfizer

GSK

AbbVie

Viatris Inc(Mylan Inc.)

Sun Pharma

Roche Holding AG

Regeneron

Piramal Enterprises Limited

Lupin Limited

Glenmark Pharmaceuticals Ltd

Dr. Reddy's Laboratories

Cipla Inc

Amgen Inc

Alkem Laboratories Limited

Alembic Pharmaceuticals Ltd

Pregnancy Medication Segment by Type

Antiallergic

Antimicrobials

Antianemia

Antacids

Laxatives

Vaccines

Nutritional Supplements

Analgesics

Others

Pregnancy Medication Segment by Application

Hospital Pharmacy

Online Pharmacy

Retail Pharmacy

Pregnancy Medication Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pregnancy Medication market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pregnancy Medication and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pregnancy Medication.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Pregnancy Medication market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Pregnancy Medication manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Pregnancy Medication in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Pregnancy Medication in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Pregnancy Medication Industry Trends Table 2. Pregnancy Medication Industry Drivers Table 3. Pregnancy Medication Industry Opportunities and Challenges Table 4. Pregnancy Medication Industry Restraints Table 5. Global Pregnancy Medication Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Pregnancy Medication Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Pregnancy Medication Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Pregnancy Medication Sales Market Share by Manufacturers Table 9. Global Pregnancy Medication Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Pregnancy Medication Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Pregnancy Medication Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Pregnancy Medication Manufacturers, Product Type & Application Table 13. Global Pregnancy Medication Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Pregnancy Medication by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Antiallergic Table 17. Major Manufacturers of Antimicrobials Table 18. Major Manufacturers of Antianemia Table 19. Major Manufacturers of Antacids Table 20. Major Manufacturers of Laxatives Table 21. Major Manufacturers of Vaccines Table 22. Major Manufacturers of Nutritional Supplements Table 23. Major Manufacturers of Analgesics Table 24. Major Manufacturers of Others Table 25. Global Pregnancy Medication Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 26. Global Pregnancy Medication Sales by Type (2021-2026) & (K Units) Table 27. Global Pregnancy Medication Sales by Type (2027-2032) & (K Units) Table 28. Global Pregnancy Medication Sales Market Share by Type (2021-2026) Table 29. Global Pregnancy Medication Sales Market Share by Type (2027-2032) Table 30. Global Pregnancy Medication Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 31. Global Pregnancy Medication Revenue by Type (2021-2026) & (K Units) Table 32. Global Pregnancy Medication Revenue by Type (2027-2032) & (K Units) Table 33. Global Pregnancy Medication Revenue Market Share by Type (2021-2026) Table 34. Global Pregnancy Medication Revenue Market Share by Type (2027-2032) Table 35. Major Manufacturers of Hospital Pharmacy Table 36. Major Manufacturers of Online Pharmacy Table 37. Major Manufacturers of Retail Pharmacy Table 38. Global Pregnancy Medication Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 39. Global Pregnancy Medication Sales by Application (2021-2026) & (K Units) Table 40. Global Pregnancy Medication Sales by Application (2027-2032) & (K Units) Table 41. Global Pregnancy Medication Sales Market Share by Application (2021-2026) Table 42. Global Pregnancy Medication Sales Market Share by Application (2027-2032) Table 43. Global Pregnancy Medication Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 44. Global Pregnancy Medication Revenue by Application (2021-2026) & (K Units) Table 45. Global Pregnancy Medication Revenue by Application (2027-2032) & (K Units) Table 46. Global Pregnancy Medication Revenue Market Share by Application (2021-2026) Table 47. Global Pregnancy Medication Revenue Market Share by Application (2027-2032) Table 48. Global Pregnancy Medication Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 49. Global Pregnancy Medication Sales by Region (2021-2026) & (K Units) Table 50. Global Pregnancy Medication Sales Market Share by Region (2021-2026) Table 51. Global Pregnancy Medication Sales Forecasted by Region (2027-2032) & (K Units) Table 52. Global Pregnancy Medication Sales Forecasted Market Share by Region (2027-2032) Table 53. North America Pregnancy Medication Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. North America Pregnancy Medication Sales by Country (2021-2026) & (K Units) Table 55. North America Pregnancy Medication Sales by Country (2027-2032) & (K Units) Table 56. Europe Pregnancy Medication Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. Europe Pregnancy Medication Sales by Country (2021-2026) & (K Units) Table 58. Europe Pregnancy Medication Sales by Country (2027-2032) & (K Units) Table 59. Asia Pacific Pregnancy Medication Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 60. Asia Pacific Pregnancy Medication Sales by Country (2021-2026) & (K Units) Table 61. Asia Pacific Pregnancy Medication Sales by Country (2027-2032) & (K Units) Table 62. South America, Middle East and Africa Pregnancy Medication Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 63. South America, Middle East and Africa Pregnancy Medication Sales by Country (2021-2026) & (K Units) Table 64. South America, Middle East and Africa Pregnancy Medication Sales by Country (2027-2032) & (K Units) Table 65. Global Pregnancy Medication Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 66. Global Pregnancy Medication Revenue by Region (2021-2026) & (US$ Million) Table 67. Global Pregnancy Medication Revenue by Region (2027-2032) & (US$ Million) Table 68. Global Pregnancy Medication Revenue Market Share by Region (2021-2026) Table 69. Global Pregnancy Medication Revenue Market Share by Region (2027-2032) Table 70. Janssen Company Information Table 71. Janssen Business Overview Table 72. Janssen Pregnancy Medication Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Janssen Pregnancy Medication Product Portfolio Table 74. Janssen Recent Development Table 75. Takeda Company Information Table 76. Takeda Business Overview Table 77. Takeda Pregnancy Medication Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Takeda Pregnancy Medication Product Portfolio Table 79. Takeda Recent Development Table 80. Sanofi Company Information Table 81. Sanofi Business Overview Table 82. Sanofi Pregnancy Medication Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Sanofi Pregnancy Medication Product Portfolio Table 84. Sanofi Recent Development Table 85. Pfizer Company Information Table 86. Pfizer Business Overview Table 87. Pfizer Pregnancy Medication Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Pfizer Pregnancy Medication Product Portfolio Table 89. Pfizer Recent Development Table 90. GSK Company Information Table 91. GSK Business Overview Table 92. GSK Pregnancy Medication Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. GSK Pregnancy Medication Product Portfolio Table 94. GSK Recent Development Table 95. AbbVie Company Information Table 96. AbbVie Business Overview Table 97. AbbVie Pregnancy Medication Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. AbbVie Pregnancy Medication Product Portfolio Table 99. AbbVie Recent Development Table 100. Viatris Inc(Mylan Inc.) Company Information Table 101. Viatris Inc(Mylan Inc.) Business Overview Table 102. Viatris Inc(Mylan Inc.) Pregnancy Medication Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. Viatris Inc(Mylan Inc.) Pregnancy Medication Product Portfolio Table 104. Viatris Inc(Mylan Inc.) Recent Development Table 105. Sun Pharma Company Information Table 106. Sun Pharma Business Overview Table 107. Sun Pharma Pregnancy Medication Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. Sun Pharma Pregnancy Medication Product Portfolio Table 109. Sun Pharma Recent Development Table 110. Roche Holding AG Company Information Table 111. Roche Holding AG Business Overview Table 112. Roche Holding AG Pregnancy Medication Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. Roche Holding AG Pregnancy Medication Product Portfolio Table 114. Roche Holding AG Recent Development Table 115. Regeneron Company Information Table 116. Regeneron Business Overview Table 117. Regeneron Pregnancy Medication Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 118. Regeneron Pregnancy Medication Product Portfolio Table 119. Regeneron Recent Development Table 120. Piramal Enterprises Limited Company Information Table 121. Piramal Enterprises Limited Business Overview Table 122. Piramal Enterprises Limited Pregnancy Medication Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 123. Piramal Enterprises Limited Pregnancy Medication Product Portfolio Table 124. Piramal Enterprises Limited Recent Development Table 125. Lupin Limited Company Information Table 126. Lupin Limited Business Overview Table 127. Lupin Limited Pregnancy Medication Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 128. Lupin Limited Pregnancy Medication Product Portfolio Table 129. Lupin Limited Recent Development Table 130. Glenmark Pharmaceuticals Ltd Company Information Table 131. Glenmark Pharmaceuticals Ltd Business Overview Table 132. Glenmark Pharmaceuticals Ltd Pregnancy Medication Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 133. Glenmark Pharmaceuticals Ltd Pregnancy Medication Product Portfolio Table 134. Glenmark Pharmaceuticals Ltd Recent Development Table 135. Dr. Reddy's Laboratories Company Information Table 136. Dr. Reddy's Laboratories Business Overview Table 137. Dr. Reddy's Laboratories Pregnancy Medication Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 138. Dr. Reddy's Laboratories Pregnancy Medication Product Portfolio Table 139. Dr. Reddy's Laboratories Recent Development Table 140. Cipla Inc Company Information Table 141. Cipla Inc Business Overview Table 142. Cipla Inc Pregnancy Medication Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 143. Cipla Inc Pregnancy Medication Product Portfolio Table 144. Cipla Inc Recent Development Table 145. Amgen Inc Company Information Table 146. Amgen Inc Business Overview Table 147. Amgen Inc Pregnancy Medication Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 148. Amgen Inc Pregnancy Medication Product Portfolio Table 149. Amgen Inc Recent Development Table 150. Alkem Laboratories Limited Company Information Table 151. Alkem Laboratories Limited Business Overview Table 152. Alkem Laboratories Limited Pregnancy Medication Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 153. Alkem Laboratories Limited Pregnancy Medication Product Portfolio Table 154. Alkem Laboratories Limited Recent Development Table 155. Alembic Pharmaceuticals Ltd Company Information Table 156. Alembic Pharmaceuticals Ltd Business Overview Table 157. Alembic Pharmaceuticals Ltd Pregnancy Medication Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 158. Alembic Pharmaceuticals Ltd Pregnancy Medication Product Portfolio Table 159. Alembic Pharmaceuticals Ltd Recent Development Table 160. Key Raw Materials Table 161. Raw Materials Key Suppliers Table 162. Pregnancy Medication Distributors List Table 163. Pregnancy Medication Customers List Table 164. Research Programs/Design for This Report Table 165. Authors List of This Report Table 166. Secondary Sources Table 167. Primary Sources List of Figures Figure 1. Pregnancy Medication Product Image Figure 2. Global Pregnancy Medication Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pregnancy Medication Market Size (2021-2032) & (US$ Million) Figure 4. Global Pregnancy Medication Sales (2021-2032) & (K Units) Figure 5. Global Pregnancy Medication Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Pregnancy Medication Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Antiallergic Image Figure 9. Antimicrobials Image Figure 10. Antianemia Image Figure 11. Antacids Image Figure 12. Laxatives Image Figure 13. Vaccines Image Figure 14. Nutritional Supplements Image Figure 15. Analgesics Image Figure 16. Others Image Figure 17. Global Pregnancy Medication Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 18. Global Pregnancy Medication Sales Market Share 2021 VS 2025 VS 2032 Figure 19. Global Pregnancy Medication Sales Market Share by Type (2021-2032) Figure 20. Global Pregnancy Medication Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Pregnancy Medication Revenue Market Share 2021 VS 2025 VS 2032 Figure 22. Global Pregnancy Medication Revenue Market Share by Type (2021-2032) Figure 23. Hospital Pharmacy Image Figure 24. Online Pharmacy Image Figure 25. Retail Pharmacy Image Figure 26. Global Pregnancy Medication Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 27. Global Pregnancy Medication Sales Market Share 2021 VS 2025 VS 2032 Figure 28. Global Pregnancy Medication Sales Market Share by Application (2021-2032) Figure 29. Global Pregnancy Medication Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 30. Global Pregnancy Medication Revenue Market Share 2021 VS 2025 VS 2032 Figure 31. Global Pregnancy Medication Revenue Market Share by Application (2021-2032) Figure 32. North America Pregnancy Medication Sales and Growth Rate (2021-2032) & (K Units) Figure 33. North America Pregnancy Medication Sales Market Share by Country (2021-2032) Figure 34. U.S. Pregnancy Medication Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Canada Pregnancy Medication Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Mexico Pregnancy Medication Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Europe Pregnancy Medication Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Europe Pregnancy Medication Sales Market Share by Country (2021-2032) Figure 39. Germany Pregnancy Medication Sales and Growth Rate (2021-2032) & (K Units) Figure 40. France Pregnancy Medication Sales and Growth Rate (2021-2032) & (K Units) Figure 41. U.K. Pregnancy Medication Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Italy Pregnancy Medication Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Netherlands Pregnancy Medication Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Asia Pacific Pregnancy Medication Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Asia Pacific Pregnancy Medication Sales Market Share by Country (2021-2032) Figure 46. China Pregnancy Medication Sales and Growth Rate (2021-2032) & (K Units) Figure 47. Japan Pregnancy Medication Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Korea Pregnancy Medication Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Southeast Asia Pregnancy Medication Sales and Growth Rate (2021-2032) & (K Units) Figure 50. India Pregnancy Medication Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Australia Pregnancy Medication Sales and Growth Rate (2021-2032) & (K Units) Figure 52. South America, Middle East and Africa Pregnancy Medication Sales and Growth Rate (2021-2032) & (K Units) Figure 53. South America, Middle East and Africa Pregnancy Medication Sales Market Share by Country (2021-2032) Figure 54. Brazil Pregnancy Medication Sales and Growth Rate (2021-2032) & (K Units) Figure 55. South Africa Pregnancy Medication Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Saudi Arabia Pregnancy Medication Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Turkey Pregnancy Medication Sales and Growth Rate (2021-2032) & (K Units) Figure 58. Argentina Pregnancy Medication Sales and Growth Rate (2021-2032) & (K Units) Figure 59. UAE Pregnancy Medication Sales and Growth Rate (2021-2032) & (K Units) Figure 60. Egypt Pregnancy Medication Sales and Growth Rate (2021-2032) & (K Units) Figure 61. Chile Pregnancy Medication Sales and Growth Rate (2021-2032) & (K Units) Figure 62. Global Pregnancy Medication Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 63. Global Pregnancy Medication Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 64. North America Pregnancy Medication Revenue (2021-2032) & (US$ Million) Figure 65. North America Pregnancy Medication Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Europe Pregnancy Medication Revenue (2021-2032) & (US$ Million) Figure 67. Europe Pregnancy Medication Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Asia-Pacific Pregnancy Medication Revenue (2021-2032) & (US$ Million) Figure 69. Asia-Pacific Pregnancy Medication Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 70. South America, Middle East and Africa Pregnancy Medication Revenue (2021-2032) & (US$ Million) Figure 71. South America, Middle East and Africa Pregnancy Medication Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 72. Pregnancy Medication Value Chain Figure 73. Manufacturing Cost Structure Figure 74. Pregnancy Medication Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • Antiallergic
  • Antimicrobials
  • Antianemia
  • Antacids
  • Laxatives
  • Vaccines
  • Nutritional Supplements
  • Analgesics
  • Others
Applications
  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy
Companies covered
  • Janssen
  • Takeda
  • Sanofi
  • Pfizer
  • GSK
  • AbbVie
  • Viatris Inc(Mylan Inc.)
  • Sun Pharma
  • Roche Holding AG
  • Regeneron
  • Piramal Enterprises Limited
  • Lupin Limited
  • Glenmark Pharmaceuticals Ltd
  • Dr. Reddy's Laboratories
  • Cipla Inc
  • Amgen Inc
  • Alkem Laboratories Limited
  • Alembic Pharmaceuticals Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Pregnancy Medication Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Pregnancy Medication Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Pregnancy Medication Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Pregnancy Medication Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Pregnancy Medication Market Dynamics
  1. 2.1 Pregnancy Medication Industry Trends
  2. 2.2 Pregnancy Medication Industry Drivers
  3. 2.3 Pregnancy Medication Industry Opportunities and Challenges
  4. 2.4 Pregnancy Medication Industry Restraints
3 Pregnancy Medication Market by Manufacturers
  1. 3.1 Global Pregnancy Medication Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Pregnancy Medication Sales by Manufacturers (2021-2026)
  3. 3.3 Global Pregnancy Medication Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Pregnancy Medication Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Pregnancy Medication Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Pregnancy Medication Manufacturers, Product Type & Application
  7. 3.7 Global Pregnancy Medication Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Pregnancy Medication Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Pregnancy Medication Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Pregnancy Medication Tier 1, Tier 2, and Tier 3
4 Pregnancy Medication Market by Type
  1. 4.1 Pregnancy Medication Type Introduction
  2. 4.1.1 Antiallergic
  3. 4.1.2 Antimicrobials
  4. 4.1.3 Antianemia
  5. 4.1.4 Antacids
  6. 4.1.5 Laxatives
  7. 4.1.6 Vaccines
  8. 4.1.7 Nutritional Supplements
  9. 4.1.8 Analgesics
  10. 4.1.9 Others
  11. 4.2 Global Pregnancy Medication Sales by Type
  12. 4.2.1 Global Pregnancy Medication Sales by Type (2021 VS 2025 VS 2032)
  13. 4.2.2 Global Pregnancy Medication Sales by Type (2021-2032)
  14. 4.2.3 Global Pregnancy Medication Sales Market Share by Type (2021-2032)
  15. 4.3 Global Pregnancy Medication Revenue by Type
  16. 4.3.1 Global Pregnancy Medication Revenue by Type (2021 VS 2025 VS 2032)
  17. 4.3.2 Global Pregnancy Medication Revenue by Type (2021-2032)
  18. 4.3.3 Global Pregnancy Medication Revenue Market Share by Type (2021-2032)
5 Pregnancy Medication Market by Application
  1. 5.1 Pregnancy Medication Application Introduction
  2. 5.1.1 Hospital Pharmacy
  3. 5.1.2 Online Pharmacy
  4. 5.1.3 Retail Pharmacy
  5. 5.2 Global Pregnancy Medication Sales by Application
  6. 5.2.1 Global Pregnancy Medication Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pregnancy Medication Sales by Application (2021-2032)
  8. 5.2.3 Global Pregnancy Medication Sales Market Share by Application (2021-2032)
  9. 5.3 Global Pregnancy Medication Revenue by Application
  10. 5.3.1 Global Pregnancy Medication Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Pregnancy Medication Revenue by Application (2021-2032)
  12. 5.3.3 Global Pregnancy Medication Revenue Market Share by Application (2021-2032)
6 Global Pregnancy Medication Sales by Region
  1. 6.1 Global Pregnancy Medication Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pregnancy Medication Sales by Region (2021-2032)
  3. 6.2.1 Global Pregnancy Medication Sales by Region (2021-2026)
  4. 6.2.2 Global Pregnancy Medication Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Pregnancy Medication Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Pregnancy Medication Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Pregnancy Medication Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Pregnancy Medication Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Pregnancy Medication Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Pregnancy Medication Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Pregnancy Medication Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Pregnancy Medication Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Pregnancy Medication Revenue by Region
  1. 7.1 Global Pregnancy Medication Revenue by Region
  2. 7.1.1 Global Pregnancy Medication Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Pregnancy Medication Revenue by Region (2021-2026)
  4. 7.1.3 Global Pregnancy Medication Revenue by Region (2027-2032)
  5. 7.1.4 Global Pregnancy Medication Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Pregnancy Medication Revenue (2021-2032)
  8. 7.2.2 North America Pregnancy Medication Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Pregnancy Medication Revenue (2021-2032)
  11. 7.3.2 Europe Pregnancy Medication Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Pregnancy Medication Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Pregnancy Medication Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Pregnancy Medication Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Pregnancy Medication Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Janssen
  2. 8.1.1 Janssen Company Information
  3. 8.1.2 Janssen Business Overview
  4. 8.1.3 Janssen Pregnancy Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Janssen Pregnancy Medication Product Portfolio
  6. 8.1.5 Janssen Recent Developments
  7. 8.2 Takeda
  8. 8.2.1 Takeda Company Information
  9. 8.2.2 Takeda Business Overview
  10. 8.2.3 Takeda Pregnancy Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Takeda Pregnancy Medication Product Portfolio
  12. 8.2.5 Takeda Recent Developments
  13. 8.3 Sanofi
  14. 8.3.1 Sanofi Company Information
  15. 8.3.2 Sanofi Business Overview
  16. 8.3.3 Sanofi Pregnancy Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Sanofi Pregnancy Medication Product Portfolio
  18. 8.3.5 Sanofi Recent Developments
  19. 8.4 Pfizer
  20. 8.4.1 Pfizer Company Information
  21. 8.4.2 Pfizer Business Overview
  22. 8.4.3 Pfizer Pregnancy Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Pfizer Pregnancy Medication Product Portfolio
  24. 8.4.5 Pfizer Recent Developments
  25. 8.5 GSK
  26. 8.5.1 GSK Company Information
  27. 8.5.2 GSK Business Overview
  28. 8.5.3 GSK Pregnancy Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 GSK Pregnancy Medication Product Portfolio
  30. 8.5.5 GSK Recent Developments
  31. 8.6 AbbVie
  32. 8.6.1 AbbVie Company Information
  33. 8.6.2 AbbVie Business Overview
  34. 8.6.3 AbbVie Pregnancy Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 AbbVie Pregnancy Medication Product Portfolio
  36. 8.6.5 AbbVie Recent Developments
  37. 8.7 Viatris Inc(Mylan Inc.)
  38. 8.7.1 Viatris Inc(Mylan Inc.) Company Information
  39. 8.7.2 Viatris Inc(Mylan Inc.) Business Overview
  40. 8.7.3 Viatris Inc(Mylan Inc.) Pregnancy Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Viatris Inc(Mylan Inc.) Pregnancy Medication Product Portfolio
  42. 8.7.5 Viatris Inc(Mylan Inc.) Recent Developments
  43. 8.8 Sun Pharma
  44. 8.8.1 Sun Pharma Company Information
  45. 8.8.2 Sun Pharma Business Overview
  46. 8.8.3 Sun Pharma Pregnancy Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Sun Pharma Pregnancy Medication Product Portfolio
  48. 8.8.5 Sun Pharma Recent Developments
  49. 8.9 Roche Holding AG
  50. 8.9.1 Roche Holding AG Company Information
  51. 8.9.2 Roche Holding AG Business Overview
  52. 8.9.3 Roche Holding AG Pregnancy Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Roche Holding AG Pregnancy Medication Product Portfolio
  54. 8.9.5 Roche Holding AG Recent Developments
  55. 8.10 Regeneron
  56. 8.10.1 Regeneron Company Information
  57. 8.10.2 Regeneron Business Overview
  58. 8.10.3 Regeneron Pregnancy Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Regeneron Pregnancy Medication Product Portfolio
  60. 8.10.5 Regeneron Recent Developments
  61. 8.11 Piramal Enterprises Limited
  62. 8.11.1 Piramal Enterprises Limited Company Information
  63. 8.11.2 Piramal Enterprises Limited Business Overview
  64. 8.11.3 Piramal Enterprises Limited Pregnancy Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Piramal Enterprises Limited Pregnancy Medication Product Portfolio
  66. 8.11.5 Piramal Enterprises Limited Recent Developments
  67. 8.12 Lupin Limited
  68. 8.12.1 Lupin Limited Company Information
  69. 8.12.2 Lupin Limited Business Overview
  70. 8.12.3 Lupin Limited Pregnancy Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Lupin Limited Pregnancy Medication Product Portfolio
  72. 8.12.5 Lupin Limited Recent Developments
  73. 8.13 Glenmark Pharmaceuticals Ltd
  74. 8.13.1 Glenmark Pharmaceuticals Ltd Company Information
  75. 8.13.2 Glenmark Pharmaceuticals Ltd Business Overview
  76. 8.13.3 Glenmark Pharmaceuticals Ltd Pregnancy Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Glenmark Pharmaceuticals Ltd Pregnancy Medication Product Portfolio
  78. 8.13.5 Glenmark Pharmaceuticals Ltd Recent Developments
  79. 8.14 Dr. Reddy's Laboratories
  80. 8.14.1 Dr. Reddy's Laboratories Company Information
  81. 8.14.2 Dr. Reddy's Laboratories Business Overview
  82. 8.14.3 Dr. Reddy's Laboratories Pregnancy Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Dr. Reddy's Laboratories Pregnancy Medication Product Portfolio
  84. 8.14.5 Dr. Reddy's Laboratories Recent Developments
  85. 8.15 Cipla Inc
  86. 8.15.1 Cipla Inc Company Information
  87. 8.15.2 Cipla Inc Business Overview
  88. 8.15.3 Cipla Inc Pregnancy Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Cipla Inc Pregnancy Medication Product Portfolio
  90. 8.15.5 Cipla Inc Recent Developments
  91. 8.16 Amgen Inc
  92. 8.16.1 Amgen Inc Company Information
  93. 8.16.2 Amgen Inc Business Overview
  94. 8.16.3 Amgen Inc Pregnancy Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Amgen Inc Pregnancy Medication Product Portfolio
  96. 8.16.5 Amgen Inc Recent Developments
  97. 8.17 Alkem Laboratories Limited
  98. 8.17.1 Alkem Laboratories Limited Company Information
  99. 8.17.2 Alkem Laboratories Limited Business Overview
  100. 8.17.3 Alkem Laboratories Limited Pregnancy Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Alkem Laboratories Limited Pregnancy Medication Product Portfolio
  102. 8.17.5 Alkem Laboratories Limited Recent Developments
  103. 8.18 Alembic Pharmaceuticals Ltd
  104. 8.18.1 Alembic Pharmaceuticals Ltd Company Information
  105. 8.18.2 Alembic Pharmaceuticals Ltd Business Overview
  106. 8.18.3 Alembic Pharmaceuticals Ltd Pregnancy Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Alembic Pharmaceuticals Ltd Pregnancy Medication Product Portfolio
  108. 8.18.5 Alembic Pharmaceuticals Ltd Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Pregnancy Medication Value Chain Analysis
  2. 9.1.1 Pregnancy Medication Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Pregnancy Medication Production Mode & Process
  6. 9.2 Pregnancy Medication Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Pregnancy Medication Distributors
  9. 9.2.3 Pregnancy Medication Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst